These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 9696136
1. Anti-beta2-glycoprotein I and anti-prothrombin antibodies in patients with the 'antiphospholipid' syndrome: immunological specificity and clotting profiles. Kandiah DA, Krilis SA. Lupus; 1998; 7(5):323-32. PubMed ID: 9696136 [Abstract] [Full Text] [Related]
2. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome. Kandiah DA, Krilis SA. Thromb Haemost; 1998 Aug; 80(2):250-7. PubMed ID: 9716148 [Abstract] [Full Text] [Related]
3. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies. Galli M, Finazzi G, Bevers EM, Barbui T. Blood; 1995 Jul 15; 86(2):617-23. PubMed ID: 7605991 [Abstract] [Full Text] [Related]
4. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids. Takeya H, Mori T, Gabazza EC, Kuroda K, Deguchi H, Matsuura E, Ichikawa K, Koike T, Suzuki K. J Clin Invest; 1997 May 01; 99(9):2260-8. PubMed ID: 9151800 [Abstract] [Full Text] [Related]
5. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome. Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A. Haematologica; 1999 Sep 01; 84(9):829-38. PubMed ID: 10477458 [Abstract] [Full Text] [Related]
6. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies. Pengo V, Biasiolo A, Rampazzo P, Brocco T. Thromb Haemost; 1999 Feb 01; 81(2):256-8. PubMed ID: 10064002 [Abstract] [Full Text] [Related]
7. Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C. Galli M, Ruggeri L, Barbui T. Blood; 1998 Mar 15; 91(6):1999-2004. PubMed ID: 9490682 [Abstract] [Full Text] [Related]
8. Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin. Sheng Y, Hanly JG, Reddel SW, Kouts S, Guerin J, Koike T, Ichikawa K, Sturgess A, Krilis SA. Clin Exp Immunol; 2001 Jun 15; 124(3):502-8. PubMed ID: 11472415 [Abstract] [Full Text] [Related]
9. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I. Arnout J, Meijer P, Vermylen J. Thromb Haemost; 1999 Jun 15; 81(6):929-34. PubMed ID: 10404770 [Abstract] [Full Text] [Related]
10. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant. Sakakura M, Wada H, Watanabe R, Mamamuro M, Okugawa Y, Nakasaki T, Nakase T, Wakita Y, Minamikawa K, Mori Y, Nshikawa M, Shiku H. Clin Appl Thromb Hemost; 2000 Jul 15; 6(3):144-50. PubMed ID: 10898274 [Abstract] [Full Text] [Related]
11. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests. Galli M, Dlott J, Norbis F, Ruggeri L, Cler L, Triplett DA, Barbui T. Thromb Haemost; 2000 Dec 15; 84(6):1012-6. PubMed ID: 11154107 [Abstract] [Full Text] [Related]
12. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Galli M, Beretta G, Daldossi M, Bevers EM, Barbui T. Thromb Haemost; 1997 Mar 15; 77(3):486-91. PubMed ID: 9065999 [Abstract] [Full Text] [Related]
13. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Atsumi T, Ieko M, Bertolaccini ML, Ichikawa K, Tsutsumi A, Matsuura E, Koike T. Arthritis Rheum; 2000 Sep 15; 43(9):1982-93. PubMed ID: 11014348 [Abstract] [Full Text] [Related]
14. [Usefulness of silica clotting time for detection of lupus anticoagulants]. Lee HR, Kim JE, Ha SH, Kim HK, Park S, Cho HI. Korean J Lab Med; 2009 Dec 15; 29(6):497-504. PubMed ID: 20046079 [Abstract] [Full Text] [Related]
15. Anti-β2-glycoprotein I and anti-prothrombin antibodies cause lupus anticoagulant through different mechanisms of action. Noordermeer T, Molhoek JE, Schutgens REG, Sebastian SAE, Drost-Verhoef S, van Wesel ACW, de Groot PG, Meijers JCM, Urbanus RT. J Thromb Haemost; 2021 Apr 15; 19(4):1018-1028. PubMed ID: 33421291 [Abstract] [Full Text] [Related]
16. Prothrombin as cofactor for antiphospholipids. Galli M, Barbui T. Lupus; 1998 Apr 15; 7 Suppl 2():S37-40. PubMed ID: 9814670 [Abstract] [Full Text] [Related]
17. [Antiphospholipid antibodies: clinical significance and biological diagnosis]. Arnoux D, Boutière B, Sanmarco M. Ann Biol Clin (Paris); 2000 Apr 15; 58(5):557-74. PubMed ID: 11022099 [Abstract] [Full Text] [Related]
18. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome. Arvieux J, Renaudineau Y, Mane I, Perraut R, Krilis SA, Youinou P. Thromb Haemost; 2002 Apr 15; 87(4):599-605. PubMed ID: 12008941 [Abstract] [Full Text] [Related]
19. Beta2-glycoprotein I: target antigen for 'antiphospholipid' antibodies. Immunological and molecular aspects. Sheng Y, Kandiah DA, Krilis SA. Lupus; 1998 Apr 15; 7 Suppl 2():S5-9. PubMed ID: 9814663 [Abstract] [Full Text] [Related]
20. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. Inanç M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S, Isenberg DA. Br J Rheumatol; 1998 Oct 15; 37(10):1089-94. PubMed ID: 9825748 [Abstract] [Full Text] [Related] Page: [Next] [New Search]